| Tubulo-interstitial nephritis, pyelonephritis, and urinary tract infections |
Antibiotics for acute pyelonephritis in children (R) |
Renal Group |
27 |
2007 |
| |
Antibiotics for asymptomatic bacteriuria in pregnancy (R) |
Pregnancy and Childbirth Group |
14 |
2007 |
| |
Treatments for symptomatic urinary tract infections during pregnancy (R) |
Pregnancy and Childbirth Group |
10 |
2011 |
| |
Duration of treatment for asymptomatic bacteriuria during pregnancy (R) |
Pregnancy and Childbirth Group |
13 |
2011 |
| |
Routine blood cultures in the management of pyelonephritis in pregnancy for improving outcomes (R) |
Renal Group |
0 |
2015 |
| |
Procalcitonin , C-reactive protein , and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children (R) |
Renal Group |
17 |
2015 |
| |
Duration of antibacterial treatment for uncomplicated urinary tract infection in women (R) |
Renal Group |
32 |
2005 |
| |
Interventions for preventing recurrent urinary tract infection during pregnancy (R) |
Pregnancy and Childbirth Group |
1 |
2012 |
| |
Long-term antibiotics for preventing recurrent urinary tract infection in children (R) |
Renal Group |
12 |
2011 |
| |
Treatments for symptomatic urinary tract infections during pregnancy (R) |
Pregnancy and Childbirth Group |
10 |
2011 |
| |
Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies (R) |
Incontinence Group |
9 |
2012 |
| |
Types of indwelling urethral catheters for short-term catheterization in hospitalized adults (R) |
Incontinence Group |
26 |
2014 |
| |
Antibiotics for treating lower urinary tract infection in children (R) |
Renal Group |
16 |
2012 |
| |
Methenamine hippurate for preventing urinary tract infections (R) |
Renal Group |
13 |
2012 |
| |
Estrogens for preventing recurrent urinary tract infection in postmenopausal women (R) |
Renal Group |
9 |
2008 |
| |
Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children (R) |
Renal Group |
10 |
2003 |
| |
Urinary catheter policies for long-term bladder drainage (R) |
Incontinence Group |
8 |
2012 |
| |
Antimicrobial agents for treating uncomplicated urinary tract infection in women (R) |
Renal Group |
21 |
2010 |
| |
Modes of administration of antibiotics for symptomatic severe urinary tract infections (R) |
Renal Group |
15 |
2007 |
| |
Antibiotic duration for treating uncomplicated , symptomatic lower urinary tract infections in elderly women (R) |
Renal Group |
15 |
2008 |
| |
Antibiotic prophylaxis for short-term catheter bladder drainage in adults (R) |
Incontinence Group |
6 |
2013 |
| |
Cranberries for treating urinary tract infections (R) |
Renal Group |
0 |
1998 |
| |
Antibiotics for preventing recurrent urinary tract infection in non-pregnant women (R) |
Renal Group |
19 |
2004 |
| |
Cranberries for preventing urinary tract infections (R) |
Renal Group |
24 |
2012 |
| |
Routine neonatal circumcision for the prevention of urinary tract infections in infancy (R) |
Neonatal Group |
0 |
2012 |
| |
Urinary catheter policies for short-term bladder drainage in adults (R) |
Incontinence Group |
17 |
2005 |
| |
Intermittent catheterization for long-term bladder management (R) |
Incontinence Group |
31 |
2014 |
| |
Antibiotic prophylaxis for transrectal prostate biopsy (R) |
Prostatic Diseases and Urologic Cancers Group |
19 |
2011 |
| |
Short term urinary catheter policies following urogenital surgery in adults (R) |
Incontinence Group |
39 |
2006 |
| |
Washout policies in long-term indwelling urinary catheterization in adults (R) |
Incontinence Group |
5 |
2010 |
| |
Routine intraoperative ureteric stenting for kidney transplant recipients (R) |
Renal Group |
7 |
2013 |
| |
Interventions for primary vesicoureteric reflux (R) |
Renal Group |
20 |
2011 |
| |
Types of indwelling urinary catheters for long-term bladder drainage in adults (R) |
Incontinence Group |
3 |
2012 |
| |
Laser prostatectomy for benign prostatic obstruction (R) |
Prostatic Diseases and Urologic Cancers Group |
20 |
2000 |
| |
Quinolones for uncomplicated acute cystitis in women (R) |
Renal Group |
11 |
2006 |
| |
Drugs for treatment of urinary retention after surgery in adults (R) |
Incontinence Group |
7 |
2010 |
| |
Indwelling bladder catheterization as part of intraoperative and postoperative care for caesarean section (R) |
Pregnancy and Childbirth Group |
5 |
2014 |
| |
Dietary interventions for preventing complications in idiopathic hypercalciuria (R) |
Renal Group |
5 |
2014 |
| |
Interventions for covert bacteriuria in children (R) |
Renal Group |
3 |
2012 |
| |
Pharmacological interventions for preventing complications in idiopathic hypercalciuria (R) |
Renal Group |
5 |
2009 |
| |
Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy (R) |
Pregnancy and Childbirth Group |
5 |
2010 |
| |
Urinary alkalization for uncomplicated urinary tract infection (P) |
Renal Group |
N/A |
2013 |
| |
Dimercaptosuccinic acid scan versus ultrasound in screening for vesicoureteral reflux among children with urinary tract infections (P) |
Renal Group |
N/A |
2013 |
| |
Chinese herbal medicine for treating recurrent urinary tract infections in women (P) |
Renal Group |
N/A |
2013 |
| |
Probiotics for preventing urinary tract infection in people with neuropathic bladder (P) |
Renal Group |
N/A |
2013 |
| |
Probiotics for preventing urinary tract infections in adults and children (P) |
Renal Group |
N/A |
2010 |
| Kidney and other urinary organ cancers |
Targeted therapy for advanced renal cell carcinoma (R) |
Prostatic Diseases and Urologic Cancers Group |
25 |
2008 |
| |
Immunotherapy for advanced renal cell cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
37 |
2004 |
| |
Surgical management of localized renal cell carcinoma (R) |
Prostatic Diseases and Urologic Cancers Group |
0 |
2010 |
| |
Surgical management for upper urinary tract transitional cell carcinoma (R) |
Prostatic Diseases and Urologic Cancers Group |
1 |
2011 |
| Urolithiasis |
Extracorporeal shock wave lithotripsy (ESWL ) versus percutaneous nephrolithotomy (PCNL ) or retrograde intrarenal surgery (RIRS ) for kidney stones (R) |
Renal Group |
5 |
2014 |
| |
Dietary interventions for preventing complications in idiopathic hypercalciuria (R) |
Renal Group |
5 |
2014 |
| |
Extracorporeal shock wave lithotripsy (ESWL ) versus ureteroscopic management for ureteric calculi (R) |
Renal Group |
7 |
2012 |
| |
Pharmacological interventions for preventing complications in idiopathic hypercalciuria (R) |
Renal Group |
5 |
2009 |
| |
Fluids and diuretics for acute ureteric colic (R) |
Renal Group |
2 |
2012 |
| |
Water for preventing urinary stones (R) |
Renal Group |
1 |
2012 |
| |
Alpha-blockers as medical expulsive therapy for ureteral stones (R) |
Renal Group |
32 |
2014 |
| |
Percussion , diuresis , and inversion therapy for the passage of lower pole kidney stones following shock wave lithotripsy (R) |
Renal Group |
2 |
2013 |
| |
Analgesia for patients undergoing shockwave lithotripsy for urinary stones (P) |
Renal Group |
N/A |
2012 |
| |
Interventions for treating urinary stones in children (P) |
Renal Group |
N/A |
2013 |
| Male infertility |
Intra-uterine insemination for male subfertility (R) |
Menstrual Disorders and Subfertility Group |
8 |
2007 |
| |
Antioxidants for male subfertility (R) |
Menstrual Disorders and Subfertility Group |
48 |
2014 |
| |
Surgery or embolization for varicoceles in subfertile men (R) |
Menstrual Disorders and Subfertility Group |
10 |
2012 |
| |
Regular (ICSI ) versus ultra-high magnification (IMSI ) sperm selection for assisted reproduction (R) |
Menstrual Disorders and Subfertility Group |
9 |
2013 |
| |
Intra-uterine insemination for unexplained subfertility (R) |
Menstrual Disorders and Subfertility Group |
8 |
2012 |
| |
Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI ) for azoospermia (R) |
Menstrual Disorders and Subfertility Group |
2 |
2008 |
| |
Cervical insemination versus intra-uterine insemination of donor sperm for subfertility (R) |
Menstrual Disorders and Subfertility Group |
4 |
2008 |
| |
Gonadotrophins for idiopathic male factor subfertility (R) |
Menstrual Disorders and Subfertility Group |
6 |
2013 |
| Benign prostatic hyperplasia |
Pygeum africanum for benign prostatic hyperplasia (R) |
Prostatic Diseases and Urologic Cancers Group |
18 |
1998 |
| |
Finasteride for benign prostatic hyperplasia (R) |
Prostatic Diseases and Urologic Cancers Group |
23 |
2010 |
| |
Beta-sitosterols for benign prostatic hyperplasia (R) |
Prostatic Diseases and Urologic Cancers Group |
4 |
1999 |
| |
Serenoa repens for benign prostatic hyperplasia (R) |
Prostatic Diseases and Urologic Cancers Group |
32 |
2012 |
| |
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia (R) |
Prostatic Diseases and Urologic Cancers Group |
|
|
| |
Microwave thermotherapy for benign prostatic hyperplasia (R) |
Prostatic Diseases and Urologic Cancers Group |
15 |
2012 |
| |
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia (P) |
Prostatic Diseases and Urologic Cancers Group |
N/A |
2012 |
| |
Laser prostatectomy for benign prostatic obstruction (R) |
Prostatic Diseases and Urologic Cancers Group |
20 |
2000 |
| |
Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction (P) |
Prostatic Diseases and Urologic Cancers Group |
N/A |
2014 |
| Prostate cancer |
5-alpha-reductase inhibitors for prostate cancer prevention (R) |
Prostatic Diseases and Urologic Cancers Group |
9 |
2008 |
| |
Screening for prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
5 |
2013 |
| |
Lycopene for the prevention of prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
3 |
2011 |
| |
Psychosocial interventions for men with prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
19 |
2013 |
| |
Radical prostatectomy versus watchful waiting for prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
2 |
2010 |
| |
Bisphosphonates for advanced prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
10 |
2006 |
| |
Cryotherapy for localized prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
8 |
2007 |
| |
Neo- adjuvant and adjuvant hormone therapy for localized and locally advanced prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
21 |
2006 |
| |
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
4 |
2001 |
| |
Chemotherapy for hormone-refractory prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
47 |
2006 |
| |
Maximal androgen blockade for advanced prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
20 |
1999 |
| |
Adjuvant radiotherapy following radical prostatectomy for prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
3 |
2011 |
| |
Intermittent versus continuous androgen suppression for prostatic cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
5 |
2007 |
| |
Low-dose rate brachytherapy for men with localized prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
1 |
2011 |
| |
Interventions for sexual dysfunction following treatments for cancer (R) |
Pain, Palliative and Supportive Care Group |
11 |
2007 |
| |
Selenium for preventing cancer (R) |
Gynaecological Cancer Group |
55 |
2014 |
| |
Green tea (Camellia sinensis) for the prevention of cancer (R) |
Gynaecological Cancer Group |
51 |
2009 |
| |
Exercise for the management of cancer-related fatigue in adults (R) |
Pain, Palliative and Supportive Care Group |
56 |
2012 |
| |
Laparoscopic versus open prostatectomy for the treatment of localized prostate cancer (P) |
Prostatic Diseases and Urologic Cancers Group |
N/A |
2012 |
| |
Non-steroidal antiandrogen monotherapy compared with luteinizing hormone –releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
11 |
2014 |
| |
Conservative management for postprostatectomy urinary incontinence (R) |
Incontinence Group |
50 |
2015 |
| |
Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery (R) |
Incontinence Group |
1 |
2014 |
| |
Antibiotic prophylaxis for transrectal prostate biopsy (R) |
Prostatic Diseases and Urologic Cancers Group |
19 |
2011 |
| Testicular cancer |
Screening for testicular cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
0 |
2011 |
| Bladder cancer |
Intravesical gemcitabine for non-muscle invasive bladder cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
6 |
2012 |
| |
Intravesical Bacillus Calmette-Guérin versus epirubicin for Ta and T1 bladder cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
5 |
2011 |
| |
Gemcitabine for unresectable , locally advanced or metastatic bladder cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
6 |
2011 |
| |
Intravesical Bacillus Calmette-Guérin in Ta and T1 bladder cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
6 |
2000 |
| |
Neo-adjuvant chemotherapy for invasive bladder cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
11 |
2004 |
| |
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
7 |
2003 |
| |
Surgery versus radiotherapy for muscle invasive bladder cancer (R) |
Prostatic Diseases and Urologic Cancers Group |
3 |
2001 |
| |
Adjuvant chemotherapy for invasive bladder cancer (individual patient data) (R) |
Prostatic Diseases and Urologic Cancers Group |
6 |
2006 |
| |
Green tea (Camellia sinensis) for the prevention of cancer (R) |
Gyanecological Cancer Group |
51 |
2009 |
| |
Perioperative nutrition for the treatment of bladder cancer by radical cystectomy (P) |
Prostatic Diseases and Urologic Cancers Group |
N/A |
2012 |
| |
Urinary diversion and bladder reconstruction /replacement using intestinal segments for intractable incontinence or following cystectomy (R) |
Incontinence Group |
5 |
2012 |
| Hydrocele due to lymphatic filariasis |
|
|
|
|
| Dysuria/bladder pathology/hydronephrosis due to schistosomiasis |
Drugs for treating urinary schistosomiasis (R) |
Infectious Diseases Group |
30 |
2014 |
| |
Therapeutic and prophylactic drug interventions for Schistosomiasis japonicum (P) |
Infectious Diseases Group |
N/A |
2012 |
| |
Rapid screening and diagnostic tests for human schistosomiasis in endemic areas (P) |
Infectious Diseases Group |
N/A |
2012 |
| |
Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy (R) |
Incontinence Group |
5 |
2012 |
